News
YI
0.9198
+49.54%
0.3047
111, Inc. Reports Third Quarter 2024 Results
TipRanks · 1d ago
111, Inc Q3 24 Earnings Conference Call AT 7:30 AM ET
NASDAQ · 1d ago
111, Inc. Achieves Sustained Profitability in Q3 2024
TipRanks · 1d ago
Earnings Scheduled For November 27, 2024
Benzinga · 2d ago
111 Net Loss Narrows In Q3, Revenues Edges Down
NASDAQ · 2d ago
111 Non-GAAP EPADS of -$0.02, revenue of $513.09M misses by $10.96M
Seeking Alpha · 2d ago
111 Q3 Adj. EPADS $(0.02) Up From $(0.12) YoY, Sales $513.09M Miss $534.67M Estimate
Benzinga · 2d ago
111 INC Q3 OPERATING EXPENSES RMB 208.2 MILLION
Reuters · 2d ago
Weekly Report: what happened at YI last week (1118-1122)?
Weekly Report · 3d ago
Weekly Report: what happened at YI last week (1111-1115)?
Weekly Report · 11/18 11:10
Weekly Report: what happened at YI last week (1104-1108)?
Weekly Report · 11/11 11:23
111, Inc. Announces Board Changes Amid Growth Plans
TipRanks · 11/04 11:47
Weekly Report: what happened at YI last week (1028-1101)?
Weekly Report · 11/04 11:20
Weekly Report: what happened at YI last week (1021-1025)?
Weekly Report · 10/28 11:13
Weekly Report: what happened at YI last week (1014-1018)?
Weekly Report · 10/21 11:09
Weekly Report: what happened at YI last week (1007-1011)?
Weekly Report · 10/14 11:37
111, Inc. announces South, Central China fulfillment centers begin operations
TipRanks · 10/10 10:15
Weekly Report: what happened at YI last week (0930-1004)?
Weekly Report · 10/07 11:27
Weekly Report: what happened at YI last week (0923-0927)?
Weekly Report · 09/30 11:19
111, Inc. discloses Nasdaq listing deficiency notice
TipRanks · 09/27 21:30
More
Webull provides a variety of real-time YI stock news. You can receive the latest news about 111 through multiple platforms. This information may help you make smarter investment decisions.
About YI
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.